<code id='AAD8723850'></code><style id='AAD8723850'></style>
    • <acronym id='AAD8723850'></acronym>
      <center id='AAD8723850'><center id='AAD8723850'><tfoot id='AAD8723850'></tfoot></center><abbr id='AAD8723850'><dir id='AAD8723850'><tfoot id='AAD8723850'></tfoot><noframes id='AAD8723850'>

    • <optgroup id='AAD8723850'><strike id='AAD8723850'><sup id='AAD8723850'></sup></strike><code id='AAD8723850'></code></optgroup>
        1. <b id='AAD8723850'><label id='AAD8723850'><select id='AAD8723850'><dt id='AAD8723850'><span id='AAD8723850'></span></dt></select></label></b><u id='AAD8723850'></u>
          <i id='AAD8723850'><strike id='AAD8723850'><tt id='AAD8723850'><pre id='AAD8723850'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:hotspot    Page View:123
          Humana sign -- health business coverage from STAT
          Humana’s Medicare Advantage business is faring even worse than the company let on last week. Ed Reinke/AP

          Humana’s Medicare Advantage business is faring even worse than the company let on last week, with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment.

          The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected. The news comes a week after Humana already lowered its projected 2023 profit, which still came in at north of $3 billion before taxes.

          advertisement

          The stock market’s punishment was swift and decisive, sinking Humana’s share price by roughly 12% at midday. Outgoing CEO Bruce Broussard worked to calm nerves on the company’s investor call, reiterating his confidence in MA. Humana went all-in on the program when it announced last year it would wind down its employer business, but that comes as regulators are beefing up scrutiny of MA plans.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Telehealth for opioid use disorder is lifesaving
          Telehealth for opioid use disorder is lifesaving

          JoeRaedle/GettyImagesThestatisticsaredismal,thoughtheybearrepeating:81%ofoverdosedeathsintheU.S.in20

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          The Readout: Gilead, Bernie Sanders, and other pharma news

          YichuanCao/SipaUSAWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechn